Brevan Howard Capital Management LP Theravance Biopharma, Inc. Transaction History
Brevan Howard Capital Management LP
- $12.7 Billion
- Q1 2024
A detailed history of Brevan Howard Capital Management LP transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 24,607 shares of TBPH stock, worth $208,667. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,607
Previous 25,268
2.62%
Holding current value
$208,667
Previous $284,000
22.54%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TBPH
# of Institutions
124Shares Held
49.6MCall Options Held
1.4KPut Options Held
2.3K-
Weiss Asset Management LP Boston, MA7.46MShares$63.2 Million2.91% of portfolio
-
Madison Avenue Partners, LP New York, NY7.01MShares$59.5 Million12.55% of portfolio
-
Seth Klarman Baupost Group LLC | Boston, Ma6.59MShares$55.9 Million1.62% of portfolio
-
Black Rock Inc. New York, NY4.21MShares$35.7 Million0.0% of portfolio
-
Irenic Capital Management LP New York, NY2.76MShares$23.4 Million5.05% of portfolio
About Theravance Biopharma, Inc.
- Ticker TBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,782,400
- Market Cap $566M
- Description
- Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...